Standard Chemical & Pharmaceutical Co., Ltd. (TPE:1720)
Taiwan · Delayed Price · Currency is TWD 64.50
+0.10 (0.16%)
Dec 3, 2025, 1:35 PM CST
TPE:1720 Market Cap
TPE:1720 has a market cap or net worth of 11.53 billion as of December 3, 2025.
Market Cap
11.53B
Enterprise Value
13.47B
Revenue
6.91B
Ranking
n/a
PE Ratio
12.91
Stock Price
64.50
Market Cap Chart
Since March 4, 1996, TPE:1720's market cap has increased from 2.29B to 11.53B, an increase of 402.43%. That is a compound annual growth rate of 5.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 2, 2025 | 11.51B | 4.04% |
| Dec 31, 2024 | 11.06B | -6.07% |
| Dec 29, 2023 | 11.78B | 7.15% |
| Dec 30, 2022 | 10.99B | 42.69% |
| Dec 30, 2021 | 7.70B | 14.32% |
| Dec 31, 2020 | 6.74B | 11.87% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 243.49B |
| PharmaEssentia | 190.47B |
| Lotus Pharmaceutical | 82.97B |
| Bora Pharmaceuticals Co., LTD. | 66.68B |
| Lin BioScience | 35.74B |
| Lumosa Therapeutics | 34.03B |
| Oneness Biotech | 32.72B |
| Center Laboratories | 28.52B |